PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS
申请人:Incyte Corporation
公开号:US20170246157A1
公开(公告)日:2017-08-31
The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.